Kathleen M. Sanzo


Kathleen M. Sanzo centers her practice on regulatory and compliance issues connected to products regulated by the US Food and Drug Administration (FDA). She leads and counsels clients on matters relating to prescription, OTC drug, and biotechnology products clinical testing; food, dietary supplement, and cosmetic product manufacture, approval, marketing, and distribution; device promotion and labeling issues; food, drug, and device compliance matters; and all consumer product issues regulated by the US Consumer Product Safety Commission (CPSC) and state enforcement agencies.


12/12/2017 - Morgan Lewis Advises Repros Therapeutics in Sale to Allergan

5/15/2017 - More than 35 Morgan Lewis Lawyers Named Top Women in the Law by Best Lawyers

6/20/2016 - Morgan Lewis Forum to Highlight Global Regulatory and Transactional Considerations for Growing Life Sciences Companies

5/3/2016 - 35 Morgan Lewis Lawyers Recognized by Best Lawyers in America as Top Women in the Law

12/4/2015 - Morgan Lewis Advises Axsome Therapeutics in $51M IPO Closing

10/15/2015 - Morgan Lewis Life Sciences Capabilities Recognized in 2015 LMG Life Sciences Guides

6/26/2015 - Morgan Lewis Represents General Econopak in $175 Million Sale to Steris Corporation

1/14/2015 - Life Sciences Group Of The Year: Morgan Lewis, Law360

11/21/2014 - Morgan Lewis Advises Merck KGaA in Global Agreement with Pfizer Inc.

9/29/2014 - LMG Life Sciences Praises Morgan Lewis’s Life Sciences Capabilities

View more...